0.00Open0.00Pre Close0 Volume0 Open Interest116.00Strike Price0.00Turnover66.16%IV-11.84%PremiumJul 26, 2024Expiry Date12.28Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9391Delta0.0175Gamma8.35Leverage Ratio-0.0825Theta-0.0085Rho-7.84Eff Leverage0.0134Vega
Abbott Laboratories Stock Discussion
The season started off last Friday with $JPMorgan(JPM.US)$ , $Wells Fargo & Co(WFC.US)$ , and $Wells Fargo & Co(WFC.US)$ sharing their numbers. They all did bett...
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
Gapping up
$United Airlines(UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
No comment yet